Famotidine Powder

Famotidine is given to surgery patients before operations to prevent postoperative nausea and to reduce the risk of aspiration pneumonitis. Famotidine is also given to some patients taking NSAIDs to prevent peptic ulcers. It serves as an alternative to proton-pump inhibitors.It is alsogiven to dogs and cats with acid reflux.Famotidine has also been used in combination with an H1 antagonist to treat and prevent urticaria caused by an acute allergic reaction.

Famotidine selectively blocks histamine H2-receptors on gastric parietal cells, suppressing basal and stimulated acid secretion. This action reduces gastric acidity, promoting ulcer healing and preventing acid-related tissue damage.

📌 Clinical Considerations

Bioavailability Enhancement: When formulated into self-nano emulsifying delivery systems (SNEDDS), famotidine powder shows improved absorption and sustained release, addressing its inherently low bioavailability.

Renal Excretion: Primarily excreted unchanged by the kidneys, requiring dosage adjustments in patients with impaired renal function to avoid accumulation.

Gastrointestinal Ulcer Management

Effectively treats and prevents peptic ulcers (stomach, duodenal, and anastomotic ulcers) by inhibiting gastric acid secretion via H2-receptor antagonism.

Reduces ulcer recurrence by maintaining optimal gastric pH (>4) for extended periods, especially when administered as a continuous infusion (20.8 hours vs. 12.6 hours with bolus dosing in critically ill patients).

Stress Ulcer Prophylaxis

Critical for ICU patients and those under surgical stress, where it prevents stress-induced gastric mucosal damage by suppressing acid production.

Gastroesophageal Reflux Disease (GERD) Relief

Alleviates symptoms like heartburn and acid regurgitation by reducing stomach acid, improving quality of life in patients with reflux esophagitis.

Upper Gastrointestinal Bleeding Control

Manages bleeding from peptic ulcers, acute stress ulcers, or hemorrhagic gastritis by stabilizing gastric pH and promoting clot formation.

Veterinary Applications

Used off-label in dogs and cats to treat acid-related disorders (e.g., gastritis, esophageal ulcers) and prevent perioperative acid reflux, with oral powder formulations allowing flexible dosing.

Formulation Flexibility

Powder form enables precise dosage adjustment, making it suitable for patients with swallowing difficulties or those requiring customized doses (e.g., children, elderly, or pets).

Drug Interaction Safety

Does not significantly inhibit the metabolism of other drugs (e.g., metoprolol), reducing the risk of adverse interactions when co-administered with cardiovascular medications.

1. Human Medicine

Peptic Ulcer Disease (PUD)

Treatment: 20 mg twice daily (or 40 mg at bedtime) for 4–8 weeks to heal gastric/duodenal ulcers; maintenance therapy with 20 mg daily to prevent recurrence.

Prophylaxis: 20 mg daily in high-risk patients (e.g., NSAID users, chronic steroid therapy).

Gastroesophageal Reflux Disease (GERD)

20 mg twice daily for up to 6 weeks to treat erosive esophagitis; 10–20 mg twice daily for symptom relief in non-erosive GERD.

Stress Ulcer Prophylaxis (SUP)

Critical care settings: 20 mg IV q12h or continuous infusion (e.g., 40 mg/24h) to prevent stress-related mucosal bleeding in mechanically ventilated patients.

Zollinger-Ellison Syndrome

Initial dose of 20 mg q6h, titrated based on acid output (max 160 mg q6h) to manage hypersecretion.

2. Veterinary Medicine (Off-Label)

Dogs & Cats

Gastritis, esophagitis, or acid reflux: 0.5–1 mg/kg PO q12h.

Prevention of perioperative reflux: Administered 1–2 hours pre-surgery.

Exotic Animals

Birds, rabbits, and reptiles with gastrointestinal ulcers: Dosed at 2–4 mg/kg PO q12–24h (species-specific adjustments required).

3. Formulation & Drug Delivery

Oral Compounding

Mixed with water, syrups, or food for patients with dysphagia (e.g., elderly, pediatric, or veterinary use).

Used in orodispersible tablets or suspensions for rapid onset of action (Tmax ~1–3 hours).

Nanoformulations

Incorporated into self-nano emulsifying systems (SNEDDS) or liposomes to enhance solubility and bioavailability.

🔬 Specialized Applications

Pediatric Patients

Safe for infants ≥1 month with GERD: 0.5 mg/kg PO q12h (max 40 mg/day).

Renal Impairment

Dosage reduced by 50% in patients with CrCl 10–50 mL/min; 75% reduction if CrCl <10 mL/min to avoid accumulation.

📌 Key Advantages in Application

Flexible Dosing: Powder form allows precise titration for individual needs (e.g., 5 mg increments for pediatric or small animal use).

Cost-Effective: Bulk powder reduces production costs compared to tablets/capsules, making it ideal for compounding pharmacies.

Stability: Stable under dry conditions (2–30°C), with reconstituted suspensions maintaining potency for 7–14 days (refrigerated).

Hot Tags: famotidine powder, China famotidine powder manufacturers, suppliers, factory, Dihydroberberine for Insulin Sensitivity, Neomycin Sulfate for Pre surgical Antibiotic, Pantethine for Immune System Health, Sulforaphane for Gut Health Support, Tetrahydrocurcumin for Anti inflammatory Benefits, Yohimbine Hydrochloride for Increased Circulation